Morgan Stanley’s Biostage, Inc. Common Stock BSTG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-10,772
| Closed | -$4K | – | 6853 |
|
|
2017
Q3 | $4K | Sell |
10,772
-1,004
| -9% | -$373 | ﹤0.01% | 6342 |
|
|
2017
Q2 | $4K | Sell |
11,776
-1,855
| -14% | -$630 | ﹤0.01% | 6398 |
|
|
2017
Q1 | $5K | Buy |
13,631
+7,726
| +131% | +$2.83K | ﹤0.01% | 6373 |
|
|
2016
Q4 | $5K | Sell |
5,905
-2,457
| -29% | -$2.08K | ﹤0.01% | 6286 |
|
|
2016
Q3 | $9K | Hold |
8,362
| – | – | ﹤0.01% | 6139 |
|
|
2016
Q2 | $10K | Sell |
8,362
-2,000
| -19% | -$2.39K | ﹤0.01% | 6068 |
|
|
2016
Q1 | $18K | Buy |
10,362
+200
| +2% | +$347 | ﹤0.01% | 5962 |
|
|
2015
Q4 | $22K | Sell |
10,162
-475
| -4% | -$1.03K | ﹤0.01% | 6009 |
|
|
2015
Q3 | $9K | Sell |
10,637
-712
| -6% | -$602 | ﹤0.01% | 6275 |
|
|
2015
Q2 | $17K | Buy |
11,349
+150
| +1% | +$225 | ﹤0.01% | 6181 |
|
|
2015
Q1 | $37K | Sell |
11,199
-36,142
| -76% | -$119K | ﹤0.01% | 5895 |
|
|
2014
Q4 | $151K | Sell |
47,341
-66,921
| -59% | -$213K | ﹤0.01% | 5372 |
|
|
2014
Q3 | $926K | Sell |
114,262
-55,449
| -33% | -$449K | ﹤0.01% | 4098 |
|
|
2014
Q2 | $1.77M | Buy |
169,711
+69,706
| +70% | +$728K | ﹤0.01% | 3576 |
|
|
2014
Q1 | $907K | Sell |
100,005
-4,123
| -4% | -$37.4K | ﹤0.01% | 4072 |
|
|
2013
Q4 | $494K | Buy |
+104,128
| New | +$494K | ﹤0.01% | 4451 |
|